Rag2 KO mice were injected subcutaneously with a low (0.5 × 106), medium (1 × 106), and high (2 × 106) number of the cetuximab-sensitive SC263-S and acquired cetuximab-resistant SC263-R cells and tumor growth was followed up over time. This evidence concerns the gene RAG2 and neoplasm.